Cymbalta is an anti-depressant which is th d rug duloxetine.
After having checked it on the Interactions Checker, it has been recommended as blelow:
sibutramine ↔ duloxetine
Applies to: Meridia (sibutramine), Cymbalta (duloxetine)
GENERALLY AVOID: Concomitant use of sibutramine with other serotonin reuptake inhibitors or other agents possessing serotonergic activity such as monoamine oxidase inhibitors, tricyclic antidepressants, 5-HT1 receptor agonists, ergot alkaloids, lithium, St. John's wort, phenylpiperidine opioids, dextromethorphan, and tryptophan may potentiate the risk of serotonin syndrome, which is a rare but serious and potentially fatal condition thought to result from hyperstimulation of brainstem 5-HT1A and 2A receptors. Symptoms of the serotonin syndrome may include mental status changes such as irritability, altered consciousness, confusion, hallucinations, and coma; autonomic dysfunction such as tachycardia, hyperthermia, diaphoresis, shivering, blood pressure lability, and mydriasis; neuromuscular abnormalities such as hyperreflexia, myoclonus, tremor, rigidity, and ataxia; and gastrointestinal symptoms such as abdominal cramping, nausea, vomiting, and diarrhea.
MANAGEMENT: In general, the concomitant use of sibutramine with other serotonergic agents should be avoided if possible, or otherwise approached with caution if potential benefit is deemed to outweigh the risk. Patients should be closely monitored for symptoms of the serotonin syndrome during treatment. Particular caution is advised when increasing the dosages of these agents. The potential risk for serotonin syndrome should be considered even when administering serotonergic agents sequentially, as some agents may demonstrate a prolonged elimination half-life. For example, a 5-week washout period is recommended following use of fluoxetine before administering another serotonergic agent such as sibutramine. At least 14 days should elapse between discontinuation of other serotonergic agents and initiation of treatment with sibutramine. If serotonin syndrome develops or is suspected during the course of therapy, all serotonergic agents should be discontinued immediately and supportive care rendered as necessary. Moderately ill patients may also benefit from the administration of a serotonin antagonist (e.g., cyproheptadine, chlorpromazine). Severe cases should be managed under consultation with a toxicologist and may require sedation, neuromuscular paralysis, intubation, and mechanical ventilation in addition to the other measures.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Duloxetine - I started taking Cymbalta 30mg 4 days ago. Seeing vivid images, restless at night , not
Posted 30 Jun 2013 • 4 answers
Posted 8 Oct 2013 • 3 answers
Posted 15 Feb 2015 • 3 answers
Posted 16 Jan 2016 • 2 answers
Posted 9 Jan 2018 • 2 answers